Vistagen Therapeutics (VTGN) Total Debt Growth (5y) (2016 - 2023)
Vistagen Therapeutics (VTGN) Total Debt Growth (5y) (2016 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Vistagen Therapeutics | 10.49 Mn | 10.49 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 34.06% |
| Mar 31, 2023 | -0.47% |
| Dec 31, 2022 | 57.17% |
| Sep 30, 2022 | 47.32% |
| Jun 30, 2022 | 44.37% |
| Dec 31, 2019 | -56.05% |
| Mar 31, 2019 | 99.79% |
| Dec 31, 2018 | 36.66% |
| Sep 30, 2018 | 30.97% |
| Mar 31, 2018 | 97.36% |
| Dec 31, 2017 | -44.40% |
| Sep 30, 2017 | -33.60% |
| Jun 30, 2017 | -29.80% |
| Mar 31, 2017 | -28.40% |
| Mar 31, 2016 | -6.59% |